Europese Unie - Engels - EMA (European Medicines Agency)

dechra regulatory b.v. - meloxicam - musculo-skeletal system, anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats - catsalleviation of inflammation and pain in chronic musculoskeletal disorders.dogsalleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.

Nieuw-Zeeland - Engels - Ministry for Primary Industries

le vet beheer b.v. - meloxicam - meloxicam 1.5 g/litre - anti-inflammatory

Nieuw-Zeeland - Engels - Ministry for Primary Industries

le vet beheer b.v. - meloxicam - meloxicam 0.5 g/litre - anti-inflammatory

Verenigd Koninkrijk - Engels - VMD (Veterinary Medicines Directorate)

le vet b.v. - meloxicam - oral suspension - anti inflammatory nsaid - cats

Verenigd Koninkrijk - Engels - VMD (Veterinary Medicines Directorate)

le vet b.v. - meloxicam - oral suspension - anti inflammatory nsaid - dogs

Verenigd Koninkrijk - Engels - VMD (Veterinary Medicines Directorate)

dechra regulatory bv - meloxicam - oral suspension - anti inflammatory nsaid - cats

Verenigd Koninkrijk - Engels - VMD (Veterinary Medicines Directorate)

dechra regulatory bv - meloxicam - oral suspension - anti inflammatory nsaid - dogs

Verenigde Staten - Engels - NLM (National Library of Medicine)

henry schein animal health - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 1.5 mg in 1 ml - eloxioral oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dogs with known hypersensitivity to meloxicam should not receive eloxioral oral suspension. do not use eloxioral oral suspension in cats. acute renal failure and death have been associated with the use of meloxicam in cats.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - meloxicam, quantity: 15 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; maize starch; sodium citrate dihydrate; colloidal anhydrous silica; magnesium stearate - meloxicam-dp is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; maize starch; sodium citrate dihydrate; colloidal anhydrous silica; magnesium stearate - meloxicam-dp is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.